Inhibrx Biosciences Inc. (INBX) Balance Sheet Analysis - Assets, Liabilities & Financial Position - Stocknear
Stocknear Logo Stocknear
/
Popular
  • KO Coca Cola Company Stock
  • TSLA Tesla Inc Stock
  • AMD Advanced Micro Devices Stock
  • SPY SPDR S&P 500 ETF Trust ETF
  • NVDA Nvidia Stock
    • Start Trial

    Inhibrx Biosciences Inc.

    NASDAQ: INBX · Real-Time Price · USD
    32.68
    0.84 (2.62%)
    At close: Sep 26, 2025, 3:59 PM
    32.68
    0.00%
    After-hours: Sep 26, 2025, 07:22 PM EDT

    Inhibrx Biosciences Balance Sheet Statement

    Financials in USD. Fiscal year is January - December.

    undefined peaked at n/a in undefined and hit its lowest at n/a in undefined. Over the past five years, it has declined by undefined%.

    Fiscal Year FY 2024 FY 2023 FY 2022 FY 2021
    Period Ending Dec 31, 2024 Dec 31, 2023 Dec 31, 2022 Dec 31, 2021
    Cash & Equivalents
    		 152.6M 277.92M 273.87M 131.3M
    Short-Term Investments
    		 n/a n/a n/a n/a
    Long-Term Investments
    		 n/a n/a n/a n/a
    Other Long-Term Assets
    		 6.83M 3.16M 3.16M 1.85M
    Receivables
    		 420K 778K 257K 878K
    Inventory
    		 n/a n/a -257K -878K
    Other Current Assets
    		 816K 366K 1.3M 7.81M
    Total Current Assets
    		 160.4M 295.36M 280.49M 139.11M
    Property-Plant & Equipment
    		 13.54M 9.37M 7.22M 9.49M
    Goodwill & Intangibles
    		 n/a n/a n/a n/a
    Total Long-Term Assets
    		 20.37M 12.54M 10.38M 11.34M
    Total Assets
    		 180.77M 307.89M 290.88M 150.45M
    Account Payables
    		 9.24M 8.31M 8.33M 9.13M
    Deferred Revenue
    		 n/a n/a 166K 2.03M
    Short-Term Debt
    		 1.59M 2.06M 1.86M 1.67M
    Other Current Liabilities
    		 22.16M 37.37M 11.99M 9.62M
    Total Current Liabilities
    		 40.73M 56.31M 27.58M 22.45M
    Long-Term Debt
    		 6.45M 206.97M 202.07M 75.5M
    Other Long-Term Liabilities
    		 n/a n/a n/a 110K
    Total Long-Term Liabilities
    		 6.45M 208.08M 205.24M 75.61M
    Total Liabilities
    		 47.18M 264.39M 232.82M 98.07M
    Total Debt
    		 8.05M 210.14M 207.1M 70.47M
    Book Value
    		 133.58M 43.5M 58.06M 52.38M
    Book Value Per Share
    		 9.23 0.92 1.45 1.38
    Common Stock
    		 1K 5K 4K 4K
    Retained Earnings
    		 -106.13M -613.73M -372.37M -227.15M
    Comprehensive Income
    		 n/a n/a n/a -150.45M
    Shareholders Equity
    		 133.58M 43.5M 58.06M 52.38M
    Total Investments
    		 n/a n/a n/a n/a

    Add to Watchlist